- Supply chain disruptions due to geopolitical risks.
- Digital mental health programs not meeting expectations.
- Lower overall market development impacting Zubsolv sales.
- MODIA study did not meet primary endpoints.
Orexo AB (publ)
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, Orexo AB (publ) disclosed greenhouse gas emissions of 1.8K tCO2e/year (2023). By scope: Scope 1: 273 tCO2e/year (2023); Scope 2: 73 tCO2e/year (2023); Scope 3: 1.5K tCO2e/year (2023). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
1.8K tCO2e/year (2023)
2023
Renewable Energy
94.9% (2023)
of total energy
Waste
6.1K kg/year (2023)
2023
Energy Use
3.1K MWh/year (2023)
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 273 tCO2e/year (2023) |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 73 tCO2e/year (2023) |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 1.5K tCO2e/year (2023) |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- Reduced greenhouse gas emissions by 3.2% (scope 1 and 2) and 10% (scope 1-3) from 2022.
- 100% of commercial suppliers have approved sustainability assessments.
- Completed mapping of scope 3 emissions according to the Greenhouse Gas Protocol.
🎯 Climate & Sustainability Targets
🔜 Short-term
- EBITDA profitability for FY 2024.
- Launch of OX124 in late 2024 (pending FDA approval).
📅 Medium-term
- At least one drug based on AmorphOX platform reaching global markets by 2030.
- 100% reimbursement for Orexo’s pharmaceutical products and growing share in Medicaid segment by 2030.
🔭 Long-term
- Reduce greenhouse gas emissions by 50% (scope 1 and 2) and 20% (scope 1-3) by 2030.
🌱 ESG Focus Areas
Access to healthcareEthical businessResponsible manufacturingClimate changeResponsible procurementWellbeing for employees